Literature DB >> 1789543

Boundaries and wounds, glia and glycoconjugates. Cellular and molecular analyses of developmental partitions and adult brain lesions.

E D Laywell1, D A Steindler.   

Abstract

During brain development, transient partitions of glia and glycoconjugates (glycoproteins, glycolipids, and glycosaminoglycans) surround forming functional units (e.g., nuclear divisions, whisker-related barrels, and neostriatal striosomes). These partitions, which we think of as boundaries, consist of dense aggregates of glial fibrillary acidic protein (GFAP)-positive radial glia, young astrocytes and their processes, and developmentally regulated glycoconjugates (e.g., J1/tenascin and the 473 proteoglycan) that can be thought of as recognition molecules present on membranes or perhaps within the extracellular matrix. When functional patterns have formed and appear to be stabilized, these boundaries are no longer detectable. Lesions of the developing brain show the existence of a more global astrocytic distribution suggestive of biochemically distinct subsets of astrocytes that reside within boundary versus nonboundary positions. Lesions of the adult brain, in addition to showing gliosis, reveal a reexpression of some of the same macromolecules present in transient brain boundaries during development. It is postulated that developmental boundaries and wounds in the adult brain possess some of the same inhibitory and possibly alluring molecular substrates for neuritic expansion.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1789543     DOI: 10.1111/j.1749-6632.1991.tb15603.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  14 in total

1.  DSD-1-proteoglycan is the mouse homolog of phosphacan and displays opposing effects on neurite outgrowth dependent on neuronal lineage.

Authors:  J Garwood; O Schnädelbach; A Clement; K Schütte; A Bach; A Faissner
Journal:  J Neurosci       Date:  1999-05-15       Impact factor: 6.167

2.  Cytokines regulate microglial adhesion to laminin and astrocyte extracellular matrix via protein kinase C-dependent activation of the alpha6beta1 integrin.

Authors:  Richard Milner; Iain L Campbell
Journal:  J Neurosci       Date:  2002-03-01       Impact factor: 6.167

Review 3.  Chondroitin sulphate proteoglycans: preventing plasticity or protecting the CNS?

Authors:  K E Rhodes; J W Fawcett
Journal:  J Anat       Date:  2004-01       Impact factor: 2.610

4.  Age-related expression patterns of the CD15 epitope in the human lateral geniculate nucleus (LGN).

Authors:  J K Mai; C Schönlau
Journal:  Histochem J       Date:  1992-11

Review 5.  Central nervous system lesions that can and those that cannot be repaired with the help of olfactory bulb ensheathing cell transplants.

Authors:  Manuel Nieto-Sampedro
Journal:  Neurochem Res       Date:  2003-11       Impact factor: 3.996

Review 6.  Extracellular matrix of the central nervous system: from neglect to challenge.

Authors:  Dieter R Zimmermann; María T Dours-Zimmermann
Journal:  Histochem Cell Biol       Date:  2008-08-12       Impact factor: 4.304

7.  Existence of tenascin-C isoforms in rat that contain the alternatively spliced AD1 domain are developmentally regulated during hippocampal development.

Authors:  J Garwood; U Theocharidis; V Calco; A Dobbertin; A Faissner
Journal:  Cell Mol Neurobiol       Date:  2011-10-04       Impact factor: 5.046

8.  Interaction between amyloid-β pathology and cortical functional columnar organization.

Authors:  Shlomit Beker; Vered Kellner; Lucia Kerti; Edward A Stern
Journal:  J Neurosci       Date:  2012-08-15       Impact factor: 6.167

9.  Murine oligodendroglial cells express nerve growth factor.

Authors:  S Byravan; L M Foster; T Phan; A N Verity; A T Campagnoni
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

10.  Common astrocytic programs during brain development, injury and cancer.

Authors:  Daniel J Silver; Dennis A Steindler
Journal:  Trends Neurosci       Date:  2009-05-03       Impact factor: 13.837

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.